Literature DB >> 21840577

Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading.

Adil Ouzzane1, Philippe Puech, Laurent Lemaitre, Xavier Leroy, Pierre Nevoux, Nacim Betrouni, Georges-Pascal Haber, Arnauld Villers.   

Abstract

OBJECTIVES: To assess the efficacy of magnetic resonance imaging (MRI) in detection of suspicious anterior prostate lesions, and its role in staging and grading of anterior prostate cancer (APC).
METHODS: Between January 2008 and August 2009, 243 patients had prostate cancer diagnosed at 12-cores posterior systematic biopsies and additional 2-cores transrectal ultrasound-guided, free-hand-targeted biopsy at any area suspicious for malignancy at prebiopsy multiparametric MRI. We conducted a retrospective study of 45 of 243 (19%) patients with an area suspicious for malignancy at MRI predominantly located in the anterior part of the gland, for which targeted biopsies were positive. Targeted vs systematic biopsy cancer detection rate and upgrading based on length of cancer in the most involved core and Gleason score were measured.
RESULTS: Of the 45 patients, 46 separate APCs were identified at MRI with positive targeted biopsies. APC was not detected by systematic biopsies in 21 (46%) cases and detected in 25 (54%) cases. For these 25 cases, median cancer length of the most involved core in targeted compared with systematic biopsies was 8 mm vs 1 mm (P <.001), respectively. Significant Gleason score upgrading was observed in 11 of 25 (44%) cases. Correlation coefficient between the cancer length on targeted biopsies and the antero-posterior diameter of the area suspicious for malignancy on MRI was r(2) = .6 (P <.001). Separate posterior cancer was diagnosed in 26 patients.
CONCLUSIONS: Targeted biopsies based on a prebiopsy MRI-detected lesion improved detection rate, volume, and grade of APC compared with currently used 12-cores systematic biopsies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21840577     DOI: 10.1016/j.urology.2011.06.022

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  46 in total

1.  Preliminary experience with a novel method of three-dimensional co-registration of prostate cancer digital histology and in vivo multiparametric MRI.

Authors:  C Orczyk; H Rusinek; A B Rosenkrantz; A Mikheev; F-M Deng; J Melamed; S S Taneja
Journal:  Clin Radiol       Date:  2013-08-28       Impact factor: 2.350

2.  Incremental value of transition zone and midline apical biopsy at baseline TRUS-guided biopsy for prostate cancer detection.

Authors:  D M Somford; W Vreuls; T S Jansen; J P van Basten; H Vergunst
Journal:  World J Urol       Date:  2013-07-20       Impact factor: 4.226

Review 3.  Transperineal biopsy of the prostate--is this the future?

Authors:  Dwayne T S Chang; Benjamin Challacombe; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2013-09-24       Impact factor: 14.432

4.  Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?

Authors:  Richard Hoffmann; Callum Logan; Michael O'Callaghan; Kirsten Gormly; Ken Chan; Darren Foreman
Journal:  Int Urol Nephrol       Date:  2017-11-29       Impact factor: 2.370

5.  The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men.

Authors:  Michael Kongnyuy; Abhinav Sidana; Arvin K George; Akhil Muthigi; Amogh Iyer; Michele Fascelli; Meet Kadakia; Thomas P Frye; Richard Ho; Francesca Mertan; M Minhaj Siddiqui; Daniel Su; Maria J Merino; Baris Turkbey; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  Urol Oncol       Date:  2016-02-20       Impact factor: 3.498

6.  MRI-directed cognitive fusion-guided biopsy of the anterior prostate tumors.

Authors:  Ian G Murphy; Elaine NiMhurchu; Robert G Gibney; Colm J McMahon
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

7.  Imaging of prostate cancer: a platform for 3D co-registration of in-vivo MRI ex-vivo MRI and pathology.

Authors:  Clement Orczyk; Artem Mikheev; Andrew B Rosenkrantz; Jonathan Melamed; Samir S Taneja; Henry Rusinek
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2012-02-23

8.  Role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer.

Authors:  Soroush Rais-Bahrami; Baris Turkbey; Kinzya B Grant; Peter A Pinto; Peter L Choyke
Journal:  Curr Urol Rep       Date:  2014-03       Impact factor: 3.092

9.  The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer.

Authors:  François Marliere; Philippe Puech; Ahmed Benkirane; Arnauld Villers; Laurent Lemaitre; Xavier Leroy; Nacim Betrouni; Adil Ouzzane
Journal:  World J Urol       Date:  2014-05-12       Impact factor: 4.226

10.  Posterior subcapsular prostate cancer: identification with mpMRI and MRI/TRUS fusion-guided biopsy.

Authors:  Sandeep Sankineni; Arvin K George; Anna M Brown; Soroush Rais-Bahrami; Bradford J Wood; Maria J Merino; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  Abdom Imaging       Date:  2015-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.